{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:51Z","timestamp":1792787991063,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology","award":["20H03828"],"award-info":[{"award-number":["20H03828"]}],"id":[{"id":"https:\/\/ror.org\/048rj2z13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology","award":["21K09457"],"award-info":[{"award-number":["21K09457"]}],"id":[{"id":"https:\/\/ror.org\/048rj2z13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"AMED","award":["JP24ama221416h0003"],"award-info":[{"award-number":["JP24ama221416h0003"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Grants from the Minoru Sano Memorial Fund","award":["23I326218"],"award-info":[{"award-number":["23I326218"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08539-7","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:44:03Z","timestamp":1782902643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing the positive predictive value of early-stage ovarian cancer detection using a two-step machine learning framework"],"prefix":"10.1186","volume":"24","author":[{"given":"Mikio","family":"Mikami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2671-1217","authenticated-orcid":false,"given":"Kazuhiro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Nagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masae","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruya","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuru","family":"Ohhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Katahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan H.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"8539_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21:389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"key":"8539_CR2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1186\/s12889-022-13861-y","volume":"22","author":"S Zhang","year":"2022","unstructured":"Zhang S, Cheng C, Lin Z, Xiao L, Su X, Zheng L, et al. The global burden and associated factors of ovarian cancer in 1990\u20132019: findings from the Global Burden of Disease Study 2019. BMC Public Health. 2022;22:1455.","journal-title":"BMC Public Health"},{"key":"8539_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1158\/1940-6207.CAPR-19-0184","volume":"13","author":"CV Trinidad","year":"2020","unstructured":"Trinidad CV, Tetlow AL, Bantis LE, Godwin AK. Reducing ovarian cancer mortality through early detection: approaches using circulating biomarkers. Cancer Prev Res (Phila). 2020;13:241\u201352.","journal-title":"Cancer Prev Res (Phila)"},{"key":"8539_CR4","doi-asserted-by":"publisher","first-page":"20170571","DOI":"10.1259\/bjr.20170571","volume":"91","author":"R Kamal","year":"2018","unstructured":"Kamal R, Hamed S, Mansour S, Mounir Y, Abdel Sallam S. Ovarian cancer screening\u2013ultrasound; impact on ovarian cancer mortality. Br J Radiol. 2018;91:20170571.","journal-title":"Br J Radiol"},{"key":"8539_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2214\/AJR.09.3522","volume":"194","author":"VR Iyer","year":"2010","unstructured":"Iyer VR, Lee SI. MRI, CT, and PET\/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol. 2010;194:311\u201321.","journal-title":"AJR Am J Roentgenol"},{"key":"8539_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"68","author":"RC Bast Jr","year":"1981","unstructured":"Bast RC Jr., Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331\u20137.","journal-title":"J Clin Invest"},{"key":"8539_CR7","first-page":"3695","volume":"63","author":"I Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63:3695\u2013700.","journal-title":"Cancer Res"},{"key":"8539_CR8","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3390\/cancers14122885","volume":"14","author":"JM Liberto","year":"2022","unstructured":"Liberto JM, Chen SY, Shih IM, Wang TH, Wang TL. Pisanic TR 2nd. Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review. Cancers. 2022;14:2885.","journal-title":"Cancers"},{"key":"8539_CR9","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397:2182\u201393.","journal-title":"Lancet"},{"key":"8539_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bpobgyn.2020.02.010","volume":"65","author":"Z Nash","year":"2020","unstructured":"Nash Z, Menon U. Ovarian cancer screening: current status and future directions. Best Pract Res Clin Obstet Gynaecol. 2020;65:32\u201345.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"8539_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s43856-021-00037-9","volume":"1","author":"RC Bast","year":"2021","unstructured":"Bast RC, Han CY, Lu Z, Lu KH. Next steps in the early detection of ovarian cancer. Commun Med. 2021;1:36.","journal-title":"Commun Med"},{"key":"8539_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-026-02066-x","volume":"26","author":"M Aghaei","year":"2026","unstructured":"Aghaei M, Bahreiny SS, Mahdizade AH, Abbasi A, Magharati A, Yousefi-Avarvand A. Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy. Clin Exp Med. 2026;26:135.","journal-title":"Clin Exp Med"},{"key":"8539_CR13","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2589-7500(23)00245-5","volume":"6","author":"G Cai","year":"2024","unstructured":"Cai G, Huang F, Gao Y, Li X, Chi J, Xie J, et al. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study. Lancet Digit Health. 2024;6:e176\u201386.","journal-title":"Lancet Digit Health"},{"key":"8539_CR14","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.2147\/CMAR.S330591","volume":"13","author":"WC Liu","year":"2021","unstructured":"Liu WC, Li MX, Qian WX, Luo ZW, Liao WJ, Liu ZL, et al. Application of machine learning techniques to predict bone metastasis in patients with prostate cancer. Cancer Manag Res. 2021;13:8723\u201336.","journal-title":"Cancer Manag Res"},{"key":"8539_CR15","doi-asserted-by":"publisher","first-page":"20000","DOI":"10.1038\/s41598-024-70228-6","volume":"14","author":"M Mikami","year":"2024","unstructured":"Mikami M, Tanabe K, Imanishi T, Ikeda M, Hirasawa T, Yasaka M, et al. Comprehensive serum glycopeptide spectra analysis to identify early-stage epithelial ovarian cancer. Sci Rep. 2024;14:20000.","journal-title":"Sci Rep"},{"key":"8539_CR16","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/cancers12092373","volume":"12","author":"K Tanabe","year":"2020","unstructured":"Tanabe K, Ikeda M, Hayashi M, Matsuo K, Yasaka M, Machida H, et al. Comprehensive serum glycopeptide spectra analysis combined with artificial intelligence (CSGSA-AI) to diagnose early-stage ovarian cancer. Cancers. 2020;12:2373.","journal-title":"Cancers"},{"key":"8539_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12911-023-02171-x","volume":"23","author":"X Guan","year":"2023","unstructured":"Guan X, Du Y, Ma R, Teng N, Ou S, Zhao H, et al. Construction of the XGBoost model for early lung cancer prediction based on metabolic indices. BMC Med Inf Decis Mak. 2023;23:107.","journal-title":"BMC Med Inf Decis Mak"},{"key":"8539_CR18","doi-asserted-by":"publisher","first-page":"1389325","DOI":"10.3389\/fmolb.2024.1389325","volume":"11","author":"S Yasar","year":"2024","unstructured":"Yasar S, Yagin FH, Melekoglu R, Ardig\u00f2 LP. Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis. Front Mol Biosci. 2024;11:1389325.","journal-title":"Front Mol Biosci"},{"key":"8539_CR19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/nu16101537","volume":"16","author":"FH Yagin","year":"2024","unstructured":"Yagin FH, Al-Hashem F, Ahmad I, Ahmad F, Alkhateeb A. Pilot-study to explore metabolic signature of type 2 diabetes: A pipeline of tree-based machine learning and bioinformatics techniques for biomarkers discovery. Nutrients. 2024;16:1537.","journal-title":"Nutrients"},{"key":"8539_CR20","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/metabo13121204","volume":"13","author":"FH Yagin","year":"2023","unstructured":"Yagin FH, Yasar S, Gormez Y, Yagin B, Pinar A, Alkhateeb A, et al. Explainable artificial intelligence paves the way in precision diagnostics and biomarker discovery for the subclass of diabetic retinopathy in type 2 diabetics. Metabolites. 2023;13:1204.","journal-title":"Metabolites"},{"key":"8539_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/gyno.1993.1026","volume":"48","author":"Y Negishi","year":"1993","unstructured":"Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, et al. Serum and tissue measurements of CA72-4 in ovarian cancer patients. Gynecol Oncol. 1993;48:148\u201354.","journal-title":"Gynecol Oncol"},{"key":"8539_CR22","doi-asserted-by":"publisher","first-page":"7352191","DOI":"10.1155\/2023\/7352191","volume":"2023","author":"J Li","year":"2023","unstructured":"Li J, Luo Y, Dong M, Liang Y, Zhao X, Zhang Y, et al. Tree-based risk factor identification and stroke level prediction in stroke cohort study. BioMed Res Int. 2023;2023:7352191.","journal-title":"BioMed Res Int"},{"key":"8539_CR23","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.radcr.2022.05.015","volume":"17","author":"E Negr\u00e3o","year":"2022","unstructured":"Negr\u00e3o E, Flor-de-Lima B, Duarte AL, Braga AC, Portugal R, Madureira AJ. Ovarian clear cell carcinoma arising in a large endometrioma\u2014a case report with pathological correlation and literature review. Radiol Case Rep. 2022;17:2806\u201311.","journal-title":"Radiol Case Rep"},{"key":"8539_CR24","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.7150\/jca.61107","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Liu G. Endometriosis-associated ovarian clear cell carcinoma: a special entity? J Cancer. 2021;12:6773\u201386.","journal-title":"J Cancer"},{"key":"8539_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","volume":"141","author":"C Romagnolo","year":"2016","unstructured":"Romagnolo C, Leon AE, Fabricio ASC, Taborelli M, Polesel J, Del Pup L, et al. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study. Gynecol Oncol. 2016;141:303\u201311.","journal-title":"Gynecol Oncol"},{"key":"8539_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5468\/ogs.22017","volume":"65","author":"KN Kang","year":"2022","unstructured":"Kang KN, Koh EY, Jang JY, Kim CW. Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening. Obstet Gynecol Sci. 2022;65:346\u201354.","journal-title":"Obstet Gynecol Sci"},{"key":"8539_CR27","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359:926\u201330.","journal-title":"Science"},{"key":"8539_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jso.28102","volume":"132","author":"X Sui","year":"2025","unstructured":"Sui X, Ji J, Zhang H. CTCs Detection methods in vivo and in vitro and their application in tumor immunotherapy. J Surg Oncol. 2025;132:80\u20137.","journal-title":"J Surg Oncol"},{"key":"8539_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1476-4598-13-114","volume":"13","author":"VE Shaw","year":"2014","unstructured":"Shaw VE, Lane B, Jenkinson C, Cox T, Greenhalf W, Halloran CM, et al. Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. Mol Cancer. 2014;13:114.","journal-title":"Mol Cancer"},{"key":"8539_CR30","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1158\/0008-5472.CAN-11-2883","volume":"72","author":"C Wingren","year":"2012","unstructured":"Wingren C, Sandstr\u00f6m A, Segersv\u00e4rd R, Carlsson A, Andersson R, L\u00f6hr M, et al. Identification of serum biomarker signatures associated with pancreatic cancer. Cancer Res. 2012;72:2481\u201390.","journal-title":"Cancer Res"},{"key":"8539_CR31","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.7150\/thno.29247","volume":"9","author":"AW Berger","year":"2019","unstructured":"Berger AW, Schwerdel D, Reinacher-Schick A, Uhl W, Alg\u00fcl H, Friess H, et al. A blood-based multi marker assay supports the differential diagnosis of early-stage pancreatic cancer. Theranostics. 2019;9:1280\u20137.","journal-title":"Theranostics"},{"key":"8539_CR32","doi-asserted-by":"publisher","first-page":"107327482312221","DOI":"10.1177\/10732748231222109","volume":"30","author":"H Wang","year":"2023","unstructured":"Wang H, Zhou Z, Li H, Xiang W, Lan Y, Dou X, et al. Blood biomarkers panels for screening of colorectal cancer and adenoma on a machine learning-assisted detection platform. Cancer Control. 2023;30:10732748231222109.","journal-title":"Cancer Control"},{"key":"8539_CR33","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1002\/cncr.28183","volume":"119","author":"KH Lu","year":"2013","unstructured":"Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, et al. A 2-stage ovarian cancer screening strategy using the risk of ovarian cancer algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value. Cancer. 2013;119:3454\u201361.","journal-title":"Cancer"},{"key":"8539_CR34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/diagnostics14090949","volume":"14","author":"A Englisz","year":"2024","unstructured":"Englisz A, Smycz-Kuba\u0144ska M, Mielczarek-Palacz A. Sensitivity and specificity of selected biomarkers and their combinations in the diagnosis of ovarian cancer. Diagnostics. 2024;14:949.","journal-title":"Diagnostics"},{"key":"8539_CR35","unstructured":"Development of the AI system for early. detection of ovarian cancer using cancer specific glycoprotein markers and peaks from comprehensive serum glycopeptide spectra analysis (CSGSA). UMIN. https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgirecptnoR000057004. Accessed 14 Feb 2023."},{"key":"8539_CR36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.hoc.2018.07.003","volume":"32","author":"KM Elias","year":"2018","unstructured":"Elias KM, Guo J, Bast RC. Jr. Early detection of ovarian cancer. Hematol Oncol Clin North Am. 2018;32:903\u201314.","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08539-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:50:31Z","timestamp":1789955431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08539-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8539"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08539-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written informed consent, and the study was approved by the institutional review board (IRB) of Tokai University (IRB registration number: 09R-082; September 17, 2009 and 15R-237; June 17, 2019). All research methods and procedures strictly followed the ethical principles outlined in the Declaration of Helsinki and fully complied with applicable institutional, national, and international guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MM and LSI Medience Corporation applied for a patent related to this study in Japan (2019-108992). The remaining authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1200"}}